ERD 308

CAS: 2320561-35-9

Ref. 3D-VSD56135

Produktinformation

• Name: ERD 308

Beschreibung

ERD 308 is a small molecule that inhibits the proteasome-mediated degradation of proteins by inhibiting the ubiquitin-proteasome pathway. ERD 308 binds to the receptor α, which is a component of the ubiquitin ligase complex, and blocks the formation of a ternary complex with ubiquitin and an E1 enzyme. This prevents protein degradation by inhibiting the ubiquitin-proteasome system. ERD 308 has shown anticancer activity in vitro and in vivo, as well as pharmacokinetic properties that are favorable for dosing in humans. The compound has been developed as a potential treatment for breast cancer and other cancers.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 1,004.3 g/mol
• Formel: C₅₅H₆₅N₅O₉S₂
• Reinheit: Min. 95%